An elderly woman looking off into the distance.
An elderly woman looking off into the distance.

Investor Relations

Investor Relations represents MorphoSys and its equity story to the financial market and supports the Company's overall strategic communication. Through active and transparent investor relations work, the aim is to enable investors to make an informed decision of the Company.

gray
gray

Voluntary Public Takeover Offer by Novartis

Acquisition of MorphoSys by Novartis Closed

Corporate Presentations and Reports

Grandmother and grandchild
Grandmother and grandchild

Annual Report 2023

We offer insights into our company, our mission as well as our corporate and financial report, our clinical pipeline and much more.

Mother and daughter
Mother and daughter

Non-Financial Group Report 2023

We provide information on business ethics and compliance as well as social, employee and environmental issues.

Events & Conferences

INVESTOR INFORMATION

Financial Information

Financial Information

Take a closer look at our Financial Guidance and the Fundamentals of MorphoSys.

Annual General Meeting

The virtual Annual General Meeting 2024 of MorphoSys AG.

Stock

Stock Information

MorphoSys stock information in detail.

Corporate Governance

We believe that our commitment to high Corporate Governance standards will ultimately increase shareholder value.

clinical trials
Clinical trials

Our Understanding of Sustainability

We are conscious of the responsibility we share for present and future generations and see sustainable action as a prerequisite for long-term business success.

Investor Contact

JNE

DR. JULIA NEUGEBAUER

VICE PRESIDENT, GLOBAL INVESTOR RELATIONS

Tel. +49 89 89927 179
Julia.Neugebauer@morphosys.com